to develop pan-severe acute respiratory syndrome coronavirus 2 and pan-sarbecovirus vaccines and evaluate in animal models
- Funded by Gates Foundation
- Total publications:1 publications
Grant number: INV-042469
Grant search
Key facts
Disease
COVID-19Start & end year
2022Known Financial Commitments (USD)
$4,668,146Funder
Gates FoundationResearch Location
United States of AmericaLead Research Institution
Beth Israel Deaconess Medical Center Inc.Research Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
InnovationStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
N/A
1 Publication linked via Europe PMC
Last Updated:4 days ago
View all publications at Europe PMC